Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
Author:
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference30 articles.
1. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies;Lard;Am J Med.,2001
2. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis;van Aken;Ann Rheum Dis.,2004
3. A non-inferiority trial of an attenuated combination strategy (‘COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks;den Uyl;Ann Rheum Dis.,2014
4. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial;ter Wee;Ann Rheum Dis.,2015
5. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial;Konijn;Rheumatology.,2017
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MYLK*FLNB and DOCK1*LAMA2 gene–gene interactions associated with rheumatoid arthritis in the focal adhesion pathway;Frontiers in Genetics;2024-05-13
2. Systems biology approach delineates critical pathways associated with disease progression in rheumatoid arthritis;Journal of Biomolecular Structure and Dynamics;2022-09-01
3. Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming;Annals of the Rheumatic Diseases;2022-06-09
4. The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease;The Lancet Rheumatology;2022-01
5. Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis—a spin-off study of the NORD-STAR randomized clinical trial;Arthritis Research & Therapy;2021-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3